By Abbas Nazil
In March 2025, the National Biosafety Management Agency (NBMA) marked a significant milestone—ten years of pioneering efforts in regulating biotechnology and ensuring biosecurity in Nigeria.
Established under the NBMA Act of 2015, the agency has been instrumental in providing a robust regulatory framework to safeguard human health and the environment from potential adverse effects of modern biotechnology and its products, such as genetically modified organisms (GMOs).
One of NBMA’s notable achievements is the development and approval of the National Biosecurity Policy and Action Plan (2022–2026), aimed at fostering an integrated and holistic biosecurity strategy through a One Health approach.
This policy underscores the agency’s commitment to preventing, detecting, and responding to biological threats, thereby protecting the environment, human health, and the nation’s socio-economic development.
In its regulatory role, NBMA has conducted rigorous risk assessments to ensure that GMOs approved for consumption in Nigeria are safe.
The agency’s Director-General, Dr. Agnes Asagbra, affirmed that the current scientific consensus supports the safety of genetically modified foods approved in the country.
These assessments evaluate potential risks to human health, the environment, and biodiversity, considering factors such as allergenicity, toxicity, and unintended effects resulting from genetic modifications.
NBMA has also been proactive in aligning its guidelines with international treaties. In September 2023, the agency announced plans to review its biosafety guidelines to conform with global standards, particularly concerning genetically modified trees and animals.
This move ensures that Nigeria remains at the forefront of biosafety regulation, adapting to emerging biotechnological advancements.
Collaboration has been a cornerstone of NBMA’s strategy. The agency has partnered with countries like Ethiopia and Mozambique to enhance biosecurity across Africa, sharing its robust legal framework and policy guidelines.
Such partnerships not only strengthen regional biosafety systems but also position Nigeria as a leader in biotechnology regulation on the continent.
Education and capacity building have not been overlooked. NBMA has organized workshops and conferences to enhance biosafety communication among stakeholders.
For instance, in January 2025, the agency held a two-day capacity-building workshop in Abuja to improve understanding of biosafety regulations and foster effective communication strategies.
These initiatives are crucial in combating misinformation and ensuring public trust in biotechnology.
As NBMA celebrates a decade of existence, its achievements reflect a steadfast dedication to its mandate.
Through rigorous regulation, international collaboration, and public engagement, the agency has significantly contributed to the safe application of modern biotechnology in Nigeria.
Looking ahead, NBMA’s continued efforts will be vital in navigating the evolving landscape of biotechnology and biosecurity, ensuring that Nigeria remains resilient against biological threats while harnessing the benefits of scientific advancements.